Largo, United States
BioDerm, Inc. is a leading medical device manufacturer specializing in proprietary hydrocolloid products for urinary management, securement, and infection control. Established in 1990 and headquartered in Largo, FL, the company's products are distributed in over 20 countries globally. Its product lines encompass a range of urinary management devices, including Men’s Liberty Acute™ and Men’s Liberty male external catheter, CathGrip® universal securement options, FreeDerm™ Adhesive Remover, BioPlus+™ Prep Wipe, and KindKlamp™ Penile Clamp.
Men's Liberty, a non-invasive external urine collection device, has gained traction due to its user-friendly design and has seen over 5 million units used without any reportable adverse events. This innovative product is positioned as a preferable alternative to condom catheters and adult diapers, offering convenience and reducing the risk of rashes, sores, and infection.
Notably, Men’s Liberty Acute™ addresses the issue of catheter-associated urinary tract infections (CAUTIs) in institutional and hospital settings, offering a promising solution. Similarly, CathGrip® has emerged as a universal catheter securement system that is gaining recognition among healthcare professionals for its performance and versatility.
TheraSafe™, the company's FDA-approved device designed for therapeutic phlebotomy procedures, further expands BioDerm’s product portfolio, catering to a broader market. With continuous enhancement driven by research, development, and user feedback over the past decade, BioDerm is committed to product improvement and innovation.
The recent Private Equity Round investment on 11th January 2021, led by Mountaingate Capital, reflects the confidence of investors in the company's vision and prospects. With a strong focus on biotechnology and healthcare, BioDerm continues to demonstrate its commitment to addressing critical healthcare needs through innovative medical technologies.
